Secnidazole vs Metronidazole Oral — Cost, Coverage & Plan Comparison

Pick the drugs you want to compare.

Up to 4 drugsCross-class or same-class

Start with the molecules your plan spends the most on. Most useful comparisons live within the same therapeutic class — switching across classes requires deeper clinical review.

Drug 1

Drug 2

Drug 3 (optional)

Drug 4 (optional)

Side by side, line by line.

Federal data onlyNo PBM pricing assumed

Compare across

11 dimensions

Nitroimidazole Antimicrobial

Secnidazole

Brand: Solosec

First FDA approval: 2018-05-31

Nitroimidazole Antimicrobial

Metronidazole Oral

Brand: LIKMEZ

First FDA approval: 2023-10-13

Lowest NADACAcquisition cost floor across all NDCs

$283.15Per unit

$2.60Per unit

Average NADACAcross all dosage forms and strengths

$283.15Up to $283.15

$2.61Up to $2.62

Generic manufacturersActive ANDA holders — FDA Orange Book

00 total ANDAs filed

Annualized Part D spendCY2024 — CMS Part D Spending Dashboard

$88144Full year

—Full year

Part D claims (CY24)Total fills, all strengths

286233 beneficiaries

—— beneficiaries

Avg cost per claimCalculated: total spend ÷ total claims

$308Per claim, all NDCs

—Per claim, all NDCs

Part D plans surveyed2026 plan year — CMS Formulary file

329Across CMS plan year

Prior-authorization frictionPlan-NDC pairs requiring PA

1Minimal friction

—Zero PA friction

Step therapy appliedPlan-NDC pairs requiring step therapy

0None

—None

FDA shortage statusLive cross-reference vs FDA Drug Shortage Database

NoneClear

Generic availableFDA Orange Book

NoBrand-only